RGNX — REGENXBIO Inc. stock price, charts and financials

QT44REGENXBIO Inc.

REGENXBIO Inc. (NASDAQ: RGNX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
8.03
-0.19-2.31%
OverviewShort InterestFilings
RGNXQT44REGENXBIO Inc.·NASDAQ
8.03-2.31%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 03, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 27, 20264Statement of changes in beneficial ownership
Aug 27, 20263Initial statement of beneficial ownership
Aug 25, 20268-KCurrent report
Aug 24, 20268-KCurrent report
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Jul 20, 20268-KCurrent report
Jul 17, 2026FWPFree writing prospectus
Jul 17, 2026424B5Prospectus
Jul 16, 2026424B5Prospectus
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 2026SC TO-I/ASC TO-I/A
Jul 01, 2026SC TO-I/ASC TO-I/A
Jul 01, 20264Statement of changes in beneficial ownership
Jun 29, 20268-KCurrent report
Jun 04, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jun 03, 20268-KCurrent report
Jun 03, 2026SC TO-IIssuer tender offer statement
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 300
Page
▼
/ 12